This inventor holds 2 USPTO granted patents. Top assignees: The University of Tokyo, Wisconsin Alumni Research Foundation. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2023-2025
Title: Masaki Imai: Innovator in Humanized Cell Line Technology
Introduction
Masaki Imai is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of virology, particularly in the development of humanized cell lines that enhance the study of human influenza viruses. With a total of 2 patents, Imai's work is pivotal in advancing our understanding of viral behavior and stability.
Latest Patents
Imai's latest patents focus on a humanized cell line that expresses high levels of human influenza virus receptors. This innovative cell line supports the isolation and growth of human influenza viruses, such as the human A/H3 influenza virus, much more effectively than conventional unmodified cells. The propagated viruses in this cell line maintain higher genetic stability compared to those grown in traditional human virus receptor-overexpressing cells. This advancement is crucial for research and development in virology.
Career Highlights
Throughout his career, Masaki Imai has worked with esteemed organizations, including the Wisconsin Alumni Research Foundation and the University of Tokyo. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Imai has collaborated with notable scientists such as Yoshihiro Kawaoka and Kosuke Takada. These partnerships have further enriched his research and have led to significant advancements in the understanding of influenza viruses.
Conclusion
Masaki Imai's contributions to the field of virology through his innovative patents and collaborations highlight his importance as an inventor. His work on humanized cell lines is paving the way for future research and advancements in combating influenza viruses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile